The following is a summary of “Spinal Cord Stimulation Explantation and Chronic Pain: A Systematic Review and Technology Recommendations,” published in the March 2025 issue of Journal of Pain Research ...

A new development in spinal cord injury treatment is offering new hope for those facing life-altering mobility challenges ...

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Discover how a groundbreaking combination of spinal cord stimulation and rehabilitation robotics is restoring movement in ...

A muscle-stimulating implant combined with a robotic exoskeleton can help restore movement in people paralyzed by a s ...

The American Society of Pain and Neuroscience (ASPN) has just issued UPDATED guidelines for physicians using neuromodulation ...

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS ... was ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

The ARC-IM System is designed to deliver targeted, personalized spinal cord stimulation to restore function and movement after spinal cord injury and other movement disabilities. The System ...

After a second round, the U.S. FDA has accepted for review radiopharmaceutical company Telix Pharmaceuticals Ltd.’s BLA for its kidney cancer PET imaging agent, TLX250-CDx (Zircaix, ...

1. Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's. News release. Medtronic. February 24, 2025. Accessed February 26 ...